Trial Profile
Relation between Natalizumab concentration and Natalizumab-associated progressive multifocal leukoencephalopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2018
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 03 Apr 2018 New trial record